The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global nonprofit partnership focused on supporting antibacterial research. Its mission is to strengthen the pipeline of therapeutics, diagnostics and preventatives to diagnose and treat life-threatening bacterial infections. CARB-X was launched in summer of 2016 at the Boston University School of Law, where CARB-X Executive Director Professor Kevin Outterson teaches health law, corporate law, and co-directs the Health Law Program. More information...
According to PR-model, carb-x.org is ranked 557,493rd in multilingual Wikipedia, in particular this website is ranked 313,403rd in English Wikipedia.
The website is placed before resisteunarchivo.blogspot.com and after boblayton.com in the BestRef global ranking of the most important sources of Wikipedia.
